NASDAQ:GANX | Profit Breakdown | Gain Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$4.68M-$4.57M-$4.68M
2026-03-31-$5.35M-$5.43M-$5.61M
2025-12-31-$4.47M-$4.47M-$4.54M
2025-09-30-$4.79M-$4.74M-$5.28M
2025-06-30-$5.09M-$5.67M-$5.81M
2025-03-31-$4.37M-$4.43M-$4.53M
2024-12-31-$3.33M-$3.26M-$3.77M
2024-09-30-$4.46M-$4.47M-$4.49M
2024-06-30-$8.18M-$8.14M-$8.14M
2024-03-31-$4.38M-$3.99M-$4.01M
2023-12-31$0.00-$4.41M-$4.71M-$4.72M
2023-09-30-$4.89M-$4.7M-$4.72M
2023-06-30-$7.73M-$7.66M-$7.69M
2023-03-31$55,180.00-$5.23M-$5.12M-$5.14M
2022-12-31$0.00-$4.56M-$4.6M-$4.67M
2022-09-30-$4.75M-$4.55M-$4.56M
2022-06-30$95,102.00-$5.18M-$5.08M-$5.09M
2022-03-31$37,538.00-$3.29M-$3.27M-$3.27M
2021-12-31$36,341.00-$3.21M-$3.23M-$3.22M
2021-09-30$15,971.00-$4.64M-$4.66M-$4.66M
2021-06-30$81,617.00-$3.51M-$3.55M-$3.56M
2021-03-31$5,269.00-$2.47M-$2.45M-$2.45M
2020-12-31$9,139.00-$1.62M-$1.66M-$1.66M
2020-09-30$6,696.00-$819,089.00-$793,486.00-$794,371.00
2020-06-30$6,373.00-$532,465.00-$538,839.00-$543,362.00
2020-03-31$6,673.00-$512,260.00-$582,921.00-$584,268.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$18.71M-$19.3M-$20.16M
2024-12-31-$20.35M-$19.87M-$20.41M
2023-12-31$55,180.00-$22.25M-$22.19M-$22.27M
2022-12-31$132,640.00-$17.78M-$17.5M-$17.59M
2021-12-31$133,928.00-$13.83M-$13.89M-$13.89M
2020-12-31$28,881.00-$3.48M-$3.57M-$3.58M